BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brücher BL, Li Y, Schnabel P, Daumer M, Wallace TJ, Kube R, Zilberstein B, Steele S, Voskuil JL, Jamall IS. Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers. Clin Transl Med 2016;5:13. [PMID: 27053248 DOI: 10.1186/s40169-016-0093-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng N, Xiao J, Ge S, Li J, Huang J, Wu X, Zhang S, Xiang T. High-Throughput Sequencing Strategy for miR-146b-regulated circRNA Expression in Hepatic Stellate Cells. Med Sci Monit 2018;24:8699-706. [PMID: 30504757 DOI: 10.12659/MSM.910807] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
2 Wu H, Liang J. Contributions of NFKB1 -94insertion/deletion ATTG polymorphism to the susceptibility of gastrointestinal cancers: A meta-analysis. J Cell Mol Med 2021;25:10674-83. [PMID: 34672421 DOI: 10.1111/jcmm.17004] [Reference Citation Analysis]
3 Zeng JH, Xiong DD, Pang YY, Zhang Y, Tang RX, Luo DZ, Chen G. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases. Oncotarget 2017;8:35681-99. [PMID: 28415685 DOI: 10.18632/oncotarget.16051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
4 Chen M, Nie J, Liu Y, Li X, Zhang Y, Brock MV, Feng K, Wu Z, Li X, Shi L, Li S, Guo M, Mei Q, Han W. Phase Ib/II study of safety and efficacy of low-dose decitabine-primed chemoimmunotherapy in patients with drug-resistant relapsed/refractory alimentary tract cancer. Int J Cancer 2018;143:1530-40. [PMID: 29663379 DOI: 10.1002/ijc.31531] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
5 Yang X, Suo C, Zhang T, Yin X, Man J, Yuan Z, Yu J, Jin L, Chen X, Lu M, Ye W. Targeted proteomics-derived biomarker profile develops a multi-protein classifier in liquid biopsies for early detection of esophageal squamous cell carcinoma from a population-based case-control study. Biomark Res 2021;9:12. [PMID: 33597040 DOI: 10.1186/s40364-021-00266-z] [Reference Citation Analysis]
6 Shi L, Zheng M, Hou J, Zhu B, Wang X. Regulatory roles of epigenetic modulators, modifiers and mediators in lung cancer. Semin Cancer Biol 2017;42:4-12. [PMID: 27840279 DOI: 10.1016/j.semcancer.2016.11.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wu D, Wang DC, Cheng Y, Qian M, Zhang M, Shen Q, Wang X. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy. Seminars in Cancer Biology 2017;42:13-9. [DOI: 10.1016/j.semcancer.2016.11.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
8 Lu J, Wang W, Xu M, Li Y, Chen C, Wang X. A global view of regulatory networks in lung cancer: An approach to understand homogeneity and heterogeneity. Semin Cancer Biol 2017;42:31-8. [PMID: 27894849 DOI: 10.1016/j.semcancer.2016.11.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]